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‘Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the 
Svedberg flotation rate.’ – Authors’ response
We thank Drs Stellaard and Lütjohann for their interest in our study and for their question 
regarding the nature of apoB48-containing lipoprotein particles found in the VLDL1 and VLDL2 
density ranges (1). The correspondents are correct in pointing out that chylomicron remnants and 
apoB100-containing VLDL of liver origin co-exist in the VLDL1 (Sf60-400) and VLDL2 (Sf20-60) 
fractions, especially after a fat-rich meal. This is indeed what we reported in in Figure 1 (2) which 
gives examples of the apoB48 and apoB100 concentrations and tracer enrichments in these 
fractions during the postprandial phase. One of our objectives in exploring the kinetics of these two 
apoB species was precisely to address the point raised in the letter – that is, are apoB48 particles in 
VLDL generated solely from chylomicron lipolysis?
In developing an integrated model of chylomicron and VLDL metabolism (2), we did indeed start 
from the prevailing paradigm that the apoB48 appearing in the Sf 60-400 and Sf 20-60 fractions 
would be present only on chylomicron remnants (as represented by the flow from compartment 
14 to compartment 15 in the apoB48 model sub-system shown in Figure 3). However, as set out in 
detail in Supplementary figure 2, this arrangement did not fit the observed tracer data in that the 
model-predicted rise in apoB48 tracer enrichment in VLDL1 and VLDL2 consistently fell below the 
observed data points. In fact, what we did find (to our surprise it must be said) was that, over the 
first 4 hours following the fat meal, tracer enrichment in apoB48 rose simultaneously in the 
chylomicron, VLDL1 and VLDL2 fractions (see panel G in Supplementary figure 2). When we 
introduced direct input of tracer (i.e. de novo synthesis) into compartments 16/17 (VLDL1 apoB48) 
and compartments 18/19 (VLDL2 apoB48) in the model (Figure 3) then a satisfactory fit was A
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obtained to the observed data in all subjects (see panels C and D in Supplementary figure 2). Thus, 
the best explanation for our results was that the intestine, in response to the meal, released 
particles across the entire size and density range (chylomicrons-VLDL1-VLDL2) which was a new 
and important finding. Further, in an upcoming paper we are able to report in an expanded cohort 
of subjects with a wide spectrum of plasma triglyceride levels that approximately half of the 
apoB48 found in the VLDL1 and VLDL2 density ranges following a fat meal is derived from 
chylomicron lipolysis and half from direct secretion of intestinally derived VLDL-sized particles 
(Bjornson et al unpublished). 
While the idea that the intestine secretes a wider range of particle sizes during fat absorption than 
previously thought is novel, as presented in the Discussion the concept that this organ is capable of 
direct secretion of apoB48-containing VLDL sized particles is not. The phenomenon was reported in 
a kinetic investigation that used a micro-meal design to establish a quasi-steady state (3), and cell 
culture and animal model studies show that the intestine has the ability to synthesise and secrete 
lipoproteins of this size (see references 50-52 in (2)). 
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